Acetazolamide and Personality change - a phase IV clinical study of FDA data

Summary:

Personality change is reported as a side effect among people who take Acetazolamide (acetazolamide), especially for people who are male, 30-39 old, also take Amlodipine, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Personality change when taking Acetazolamide. It is created by eHealthMe based on reports of 5,933 people who have side effects when taking Acetazolamide from the FDA, and is updated regularly.

What is Acetazolamide?

Acetazolamide has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 6,178 Acetazolamide users. Check the latest studies of Acetazolamide.

What is Personality change?

Personality change is found to be associated with 726 drugs and 946 conditions by eHealthMe. Check the latest studies of Personality change.

On Jul, 06, 2026

5,933 people reported to have side effects when taking Acetazolamide.
Among them, 11 people (0.19%) have Personality change.

Could Acetazolamide cause Personality change?

Among these 11 people:

What is the gender of people who have Personality change when taking Acetazolamide? *

female: 50 %
male: 50 %

What is the age of people who have Personality change when taking Acetazolamide? *

What are other drugs people take besides Acetazolamide? *

Synthroid: 4 people, 36.36%
Norethindrone Acetate And Ethinyl Estradiol: 4 people, 36.36%
Myrbetriq: 4 people, 36.36%
Gilenya: 4 people, 36.36%
Diovan: 4 people, 36.36%
Ampyra: 4 people, 36.36%
Amlodipine: 4 people, 36.36%
Topamax: 1 person, 9.09%

What are other side effects people have besides Personality change? *

Anger: 6 people, 54.55%
Communication Disorder (speech and language disorder): 6 people, 54.55%
Social Avoidant Behavior: 6 people, 54.55%
Feeling Of Despair: 6 people, 54.55%
Irritability: 6 people, 54.55%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 36.36%
Csf Pressure Increased: 4 people, 36.36%
Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function): 4 people, 36.36%
Diplopia (double vision): 4 people, 36.36%
Drowsiness: 4 people, 36.36%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 27.27%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Acetazolamide and have Personality change?

- Check whether Personality change is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acetazolamide:

Acetazolamide (6,178 reports)

Browse all side effects of Acetazolamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Personality change:

Personality change (726 drugs)

Browse all the conditions that are associated with Personality change:

Personality change (946 conditions)

Related publications that referenced our studies

Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on acetazolamide (the active ingredients of Acetazolamide) and Acetazolamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.